Kolterman Orville G

Avg. Two Year Performance

No purchase track record
15% Avg. Sale Return
7% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return< 1%3%6%23%15%
Sale Success Rate18 of 3918 of 3919 of 3923 of 3915 of 39
Drugs » Biotechnology

SVP, Chief Medical Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--